Femasys Inc (FEMY) Stock Price, Quote & News

Company Profile

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual b...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 770 500 3910

Fax: 404 581 5903

Website: femasys.com

Address:

3950 Johns Creek Court, Suite 100, Suwanee, United States

Severian1 Sep. 5 at 7:25 PM

$FEMY still believe in Fembloc. Struggling on when to buy back in. sold my previous shares at .35 before split

2 · Reply

harambe_reborn Sep. 5 at 3:01 AM

$FEMY #fire kathy spread the word

1 · Reply

dongknotts Sep. 4 at 7:04 PM

$FEMY

0 · Reply

dongknotts Sep. 4 at 6:53 PM

$FEMY It's going to be a long time before the FINALE trial is done, enrollment is ongoing, probably into mid-2027, then 1 year trial, data analysis, etc takes a little time. Maybe 2029? This is a long way out. It seems to me the near term catalyst would be acceleration or adoption of FemBloc in Europe which would probably speed adoption in the USA once approved.

0 · Reply

Severian1 Sep. 4 at 4:20 PM

$FEMY trickle downward til next fembloc fda news?

1 · Reply

TripTrap Sep. 2 at 5:01 PM

$FEMY Looking for support @ $3.00. Wake-up!! This not the old FEMY anymore! The modular Premarket Approval (PMA) approach that just happened changes everything along with the 30M cash runway we now have! PMA means a company submits completed sections (modules) of its application to the FDA for review as they become ready, rather than waiting to compile and send a single massive file at the very end. It speeds things up by 6 months or more. REMEMBER - we already have the CE mark of approval from over in Europe. There is a 99.9% likelyhood FemBloc gets FDA approval being that Europe regulators are more stringent. Any down day for me in price is a buying opportunity at these prices. 💪🔥

0 · Reply

TripTrap Sep. 1 at 6:03 PM

$FEMY Added AGAIN on the morning dip today, Tuesday! Bullish AF now that we know the FDA is helping to make this happen!!!🔥🔥

0 · Reply

TheGodsMustBeCrazy Sep. 1 at 1:26 AM

🤡🤡🤡🤣🤣🤣🤣🤣🤣 $FEMY

1 · Reply

beart00th Aug. 31 at 11:58 PM

$FEMY not bad for a Monday.

0 · Reply

TripTrap Aug. 31 at 7:58 PM

$FEMY Added more on the morning dip. Bullish AF!💪

0 · Reply

Femasys registers to sell 28.12M shares of common stock for holders

Sep 3, 2026, 8:00 AM EDT - 3 days ago

Femasys Registration statement: Registration filing

2026-08-26T13:05:29.000Z - 11 days ago

Femasys announces fertility partnership with UNC Health

Aug 26, 2026, 9:00 AM EDT - 11 days ago

Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations

2026-08-19T13:16:53.000Z - 18 days ago

Femasys announces FDA approval of FemBloc modular premarket approval application

2026-08-18T13:20:09.000Z - 19 days ago

Femasys price target lowered to $10 from $30 at Lake Street

2026-08-17T09:26:25.000Z - 20 days ago

Femasys issued patent for FemBloc blended polymer component

2026-08-16T13:22:48.000Z - 21 days ago

Femasys price target lowered to $10 from $30 at Maxim

Aug 14, 2026, 4:05 PM EDT - 23 days ago

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

Aug 14, 2026, 7:00 AM EDT - 23 days ago

Femasys Earnings release: Q2 2026

Aug 14, 2026, 7:00 AM EDT - 23 days ago

Femasys Quarterly report: Q2 2026

Aug 12, 2026, 9:00 AM EDT - 25 days ago

Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents

2026-08-07T13:50:44.000Z - 4 weeks ago

Femasys announces $30M private placement

Aug 7, 2026, 9:25 AM EDT - 4 weeks ago

Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million

2026-06-24T13:15:18.000Z - 2 months ago

Femasys regains compliance with Nasdaq

Jun 24, 2026, 9:00 AM EDT - 2 months ago

Femasys Regains Compliance with Nasdaq Listing Requirements

2026-06-05T23:55:32.000Z - 3 months ago

Femasys Inc trading halted, news pending

2026-05-13T14:46:53.000Z - 3 months ago

Femasys announces CE Mark approval for FemHSG Catheter

May 13, 2026, 9:00 AM EDT - 3 months ago

Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter

May 13, 2026, 7:00 AM EDT - 3 months ago

Femasys Slides: Corporate presentation

May 8, 2026, 4:05 PM EDT - 4 months ago

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

May 8, 2026, 8:00 AM EDT - 4 months ago

Femasys Quarterly report: Q1 2026

May 8, 2026, 8:00 AM EDT - 4 months ago

Femasys Earnings release: Q1 2026

May 5, 2026, 9:00 AM EDT - 4 months ago

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Femasys Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Femasys Proxy statement: Proxy filing

2026-04-16T13:56:18.000Z - 4 months ago

Femasys drives growth with Israeli market entry for fertility portfolio

Apr 6, 2026, 8:00 AM EDT - 5 months ago

Femasys Proxy statement: Proxy filing

Mar 31, 2026, 4:05 PM EDT - 5 months ago

Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

Mar 31, 2026, 8:00 AM EDT - 5 months ago

Femasys Annual report: Q4 2025

Mar 31, 2026, 8:00 AM EDT - 5 months ago

Femasys Earnings release: Q4 2025

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Femasys Proxy statement: Proxy filing

2026-03-24T15:20:53.000Z - 5 months ago

Femasys management to meet virtually with Lake Street

2026-03-18T13:05:27.000Z - 5 months ago

Femasys appoints Kenneth Eichenbaum to its Board of Directors

2026-03-10T13:17:37.000Z - 6 months ago

Femasys advances FemBloc to U.S. approval with initiation of trial enrollment

2026-03-03T13:13:48.000Z - 6 months ago

Femasys initiated with a Buy at Lake Street

Feb 27, 2026, 5:26 PM EST - 6 months ago

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-02-26T14:06:51.000Z - 6 months ago

Femasys FemBloc achieved certification under MDSAP

2026-02-23T14:06:46.000Z - 6 months ago

Femasys receives AMA CPT Editorial Panel approval for new CPT code

Feb 23, 2026, 9:00 AM EST - 6 months ago

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination

2026-02-03T14:20:28.000Z - 7 months ago

Femasys enters distribution partnership with OR Consulting

2026-01-14T14:15:55.000Z - 7 months ago

Femasys granted 180-day extension by Nasdaq to regain compliance

Jan 13, 2026, 9:00 AM EST - 7 months ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Dec 31, 2025, 7:00 AM EST - 8 months ago

Femasys Registration statement: Registration filing

Dec 18, 2025, 9:15 AM EST - 8 months ago

Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device

Dec 4, 2025, 7:00 AM EST - 9 months ago

Femasys Registration statement: Registration filing

Nov 25, 2025, 9:15 AM EST - 9 months ago

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

PMCB

Nov 14, 2025, 7:00 AM EST - 9 months ago

Femasys Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 9 months ago

Femasys Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million

Oct 16, 2025, 9:00 AM EDT - 10 months ago

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo

Sep 11, 2025, 9:00 AM EDT - 12 months ago

Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®

Sep 8, 2025, 9:00 AM EDT - 12 months ago

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

Aug 25, 2025, 11:44 PM EDT - 1 year ago

Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

Aug 21, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing

Aug 20, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing

Aug 8, 2025, 4:05 PM EDT - 1 year ago

Femasys Announces Second Quarter Financial Results for 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Quarterly report: Q2 2025

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q2 2025

Aug 6, 2025, 9:00 AM EDT - 1 year ago

Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion

Jul 3, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing

Jul 1, 2025, 9:00 AM EDT - 1 year ago

Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic

Jun 25, 2025, 9:00 AM EDT - 1 year ago

Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control

Jun 17, 2025, 9:00 AM EDT - 1 year ago

Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth

Jun 11, 2025, 9:00 AM EDT - 1 year ago

Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations

May 29, 2025, 4:23 PM EDT - 1 year ago

Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

May 8, 2025, 5:01 PM EDT - 1 year ago

Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q1 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing

Mar 27, 2025, 9:00 AM EDT - 1 year ago

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Annual report: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q4 2024

Mar 19, 2025, 9:20 AM EDT - 1 year ago

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

Mar 18, 2025, 9:00 AM EDT - 1 year ago

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

Mar 13, 2025, 8:30 AM EDT - 1 year ago

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

Feb 25, 2025, 9:20 AM EST - 1 year ago

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

Feb 11, 2025, 9:00 AM EST - 1 year ago

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

Jan 30, 2025, 8:30 AM EST - 1 year ago

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

Jan 16, 2025, 8:30 AM EST - 1 year ago

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment

Nov 26, 2024, 8:30 AM EST - 1 year ago

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

Nov 12, 2024, 8:30 AM EST - 1 year ago

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Earnings release: Q3 2024

Nov 1, 2024, 8:30 AM EDT - 1 year ago

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

Oct 10, 2024, 8:30 AM EDT - 1 year ago

Femasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education Program

Oct 2, 2024, 8:30 AM EDT - 1 year ago

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

Sep 18, 2024, 8:30 AM EDT - 1 year ago

Femasys Announces Infertility Clinic Customers from Coast to Coast

Sep 11, 2024, 8:30 AM EDT - 1 year ago

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market

Sep 9, 2024, 8:30 AM EDT - 1 year ago

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

Sep 5, 2024, 8:30 AM EDT - 2 years ago

Femasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual Meeting

Sep 3, 2024, 8:30 AM EDT - 2 years ago

Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 29, 2024, 8:30 AM EDT - 2 years ago

Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution

Aug 27, 2024, 8:30 AM EDT - 2 years ago

Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Quarterly report: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Earnings release: Q2 2024

Jun 27, 2024, 8:30 AM EDT - 2 years ago

Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam

Jun 7, 2024, 8:00 AM EDT - 2 years ago

Femasys Proxy statement: Proxy filing

May 17, 2024, 8:30 AM EDT - 2 years ago

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative

Severian1 Sep. 5 at 7:25 PM

$FEMY still believe in Fembloc. Struggling on when to buy back in. sold my previous shares at .35 before split

2 · Reply

harambe_reborn Sep. 5 at 3:01 AM

$FEMY #fire kathy spread the word

1 · Reply

dongknotts Sep. 4 at 7:04 PM

$FEMY

0 · Reply

dongknotts Sep. 4 at 6:53 PM

0 · Reply

Severian1 Sep. 4 at 4:20 PM

$FEMY trickle downward til next fembloc fda news?

1 · Reply

TripTrap Sep. 2 at 5:01 PM

0 · Reply

TripTrap Sep. 1 at 6:03 PM

$FEMY Added AGAIN on the morning dip today, Tuesday! Bullish AF now that we know the FDA is helping to make this happen!!!🔥🔥

0 · Reply

TheGodsMustBeCrazy Sep. 1 at 1:26 AM

🤡🤡🤡🤣🤣🤣🤣🤣🤣 $FEMY

1 · Reply

beart00th Aug. 31 at 11:58 PM

$FEMY not bad for a Monday.

0 · Reply

TripTrap Aug. 31 at 7:58 PM

$FEMY Added more on the morning dip. Bullish AF!💪

0 · Reply

cjw1979 Aug. 31 at 7:26 PM

$FEMY let's rip. Lotta shorts to wipe

0 · Reply

topstockalerts Aug. 31 at 4:30 PM

$FEMY keep an eye on it

0 · Reply

GSP Aug. 31 at 11:40 AM

$SPY $RELY $FEMY $RCKT $AMZN

0 · Reply

XkaliburTrading Aug. 31 at 7:55 AM

☀️⚔️ Good morning, early birds! The early premarket is about to open, and it's time to lock in. The watchlist is ready, the team is prepared, and we're excited to see what opportunities today brings. I hope every one of you has an amazing day, stays disciplined, and makes the most of whatever the market gives you. The XKALIBUR TRADING Team is ready to spot bangers, smash levels, and attack the day together. LFG! 🔥📈 $NCRA $YDDL $COOT $JZ $FEMY

0 · Reply

XkaliburTrading Aug. 31 at 4:15 AM

While most are sleeping, we're still putting in the work. Preparation doesn't start at the opening bell—it starts the night before. That's how momentum is built. 🔥📈 $NCRA $COOT $YDDL $JZ $FEMY

0 · Reply

XkaliburTrading Aug. 30 at 11:22 PM

The weekend's winding down, and the excitement is building. The watchlist is locked in, the overnight market is about to open, and the TEAM is ready to attack another week together. Let's smash levels, spot bangers, and get after it. LFG! 🔥📈 $NCRA $YDDL $COOT $JZ $FEMY

2 · Reply

XkaliburTrading Aug. 30 at 8:59 PM

🔥⚔️ The work doesn't stop just because the market is closed. Putting in the preparation now is what helps us be ready when opportunity knocks next week. I hope you all have a safe, relaxing, and enjoyable rest of your weekend with your family, friends, and loved ones. We'll be back locked in and ready to fire on all cylinders before you know it. I'm excited for the week ahead. LFG, XKALIBUR TRADING Team! 📈🚀 $NCRA $AEHL $ESTC $FEMY $TRUG

0 · Reply